PEOPLE - Tamro Group (Finland) announces several new management appointments:
This article was originally published in Clinica
Tamro Group (Finland) has recently announced several new management appointments. Matti Elovaara has been named CEO and group president, and Bengt Ohlsson, managing director of ADA, becomes group vice-president. Tapio Mansukoski is appointed group CFO. Ulf Pregmark becomes director of human resources and KjellOwe Gustafsson director of information technology. The North-European Tamro Group is divided into three business areas, in which Bengt Ohlsson is named director for pharmaceutical distribution, Bjorn Mattila becomes director for the medical and laboratory business, and Jorma Turunen, managing director of Kolmi-Set, becomes director of the Kolmi-Set business.
You may also be interested in...
US FDA usually recommends using overall survival for pancreatic cancer drugs, but AstraZeneca choose progression-free survival; now ODAC will weigh in on whether the PARP inhibitor olaparib demonstrated a clinically meaningful impact. The firm cites enrollment and design challenges in the gBRCAm population as reasons for using PFS.
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.